NICE Bipolar disorder in adolescents – aripiprazole TA292

 In Clinical Guidelines, NICE guidelines

Aripiprazole (Abilify) is a licensed treatment for moderate to severe manic episodes in young people aged 13+ with bipolar 1 disorder.

Other antipsychotics,  such as quetiapine and risperidone, have a similar effectiveness, but have different side-effect profiles.

NICE recommends aripiprazole as a treatment option, so the NHS must make sure it is available for use in line with NICE’s recommendations.


By en:User:Sponge [GFDL ( or CC-BY-SA-3.0 (], via Wikimedia Commons

Recent Posts

Start typing and press Enter to search

support during medical inspectionsNeuropathic pain